Myriad Genetics
MYGN
MYGN
227 hedge funds and large institutions have $833M invested in Myriad Genetics in 2025 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 79 increasing their positions, 79 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 79
34% less capital invested
Capital invested by funds: $1.27B → $833M (-$434M)
Holders
227
Holding in Top 10
–
Calls
$854K
Puts
$170K
Top Buyers
| 1 | +$26.1M | |
| 2 | +$9.36M | |
| 3 | +$8.44M | |
| 4 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
+$6.6M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
+$5.08M |
Top Sellers
| 1 | -$17M | |
| 2 | -$9.01M | |
| 3 | -$5.88M | |
| 4 |
Pictet Asset Management
Carouge,
Switzerland
|
-$5.6M |
| 5 |
BlackRock
New York
|
-$5.4M |